Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Treasury Shares: 2011-2012

  • Lifecore Biomedical's Treasury Shares rose 325.27% to $917,244 in Q2 2012 from the same period last year, while for May 2012 it was $917,244, marking a year-over-year increase of 325.27%. This contributed to the annual value of $917,244 for FY2012, which is 325.27% up from last year.
  • Lifecore Biomedical's Treasury Shares amounted to $917,244 in Q2 2012, which was up 325.27% from $215,684 recorded in Q2 2011.
  • In the past 5 years, Lifecore Biomedical's Treasury Shares registered a high of $917,244 during Q2 2012, and its lowest value of -$215.7 million during Q1 2011.
  • In the last 2 years, Lifecore Biomedical's Treasury Shares had a median value of $215,684 in 2011 and averaged -$71.5 million.
  • Data for Lifecore Biomedical's Treasury Shares shows a peak YoY spiked of 325.27% (in 2012) over the last 5 years.
  • Quarterly analysis of 2 years shows Lifecore Biomedical's Treasury Shares stood at $215,684 in 2011, then surged by 325.27% to $917,244 in 2012.
  • Its last three reported values are $917,244 in Q2 2012, $215,684 for Q2 2011, and -$215.7 million during Q1 2011.